Header cover image

South Korean (KOSPI) Biotech Industry Analysis

UpdatedFeb 23, 2024
DataAggregated Company Financials
Companies112
  • 7D0.2%
  • 3M4.7%
  • 1Y5.6%
  • YTD-16.1%

Last week, the Biotech industry hasn't moved much but ALTEOGEN is up 16% in that time. The past year has been better, since the industry has gained 5.6% in that time. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the South Korean Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Feb 2024₩74.8t₩9.7t-₩534,696,541,747.0061.5x-139.9x7.7x
Mon, 22 Jan 2024₩72.8t₩9.7t-₩537,261,689,777.0061.3x-135.5x7.5x
Wed, 20 Dec 2023₩61.4t₩10.1t-₩311,749,314,637.0028.3x-196.9x6x
Fri, 17 Nov 2023₩57.1t₩10.2t-₩233,197,853,989.0032x-245x5.6x
Sun, 15 Oct 2023₩54.7t₩10.2t-₩239,053,318,689.0028x-229x5.4x
Tue, 12 Sep 2023₩60.1t₩10.2t-₩340,370,750,949.0034.1x-176.5x5.9x
Thu, 10 Aug 2023₩59.8t₩10.3t-₩166,675,753,149.0031x-359x5.8x
Sat, 08 Jul 2023₩55.4t₩10.3t-₩151,534,704,579.0026.5x-365.3x5.4x
Mon, 05 Jun 2023₩64.0t₩10.3t-₩151,338,675,579.0032.2x-422.7x6.2x
Wed, 03 May 2023₩60.2t₩11.0t₩317.9b24.5x189.3x5.5x
Fri, 31 Mar 2023₩56.4t₩10.9t₩346.5b23.4x162.8x5.2x
Sun, 26 Feb 2023₩57.2t₩11.3t₩968.6b24.7x59.1x5.1x
Tue, 24 Jan 2023₩58.7t₩11.3t₩970.8b24.1x60.4x5.2x
Thu, 22 Dec 2022₩61.4t₩10.8t₩197.3b26.4x311.1x5.7x
Sat, 19 Nov 2022₩62.6t₩11.1t₩359.3b20.5x174.1x5.7x
Mon, 17 Oct 2022₩57.3t₩10.8t₩348.0b20.4x164.7x5.3x
Wed, 14 Sep 2022₩64.8t₩10.8t₩495.4b23.8x130.9x6x
Fri, 12 Aug 2022₩74.7t₩10.7t₩597.6b26.4x125x7x
Sun, 10 Jul 2022₩69.1t₩10.7t₩597.6b24x115.6x6.5x
Tue, 07 Jun 2022₩68.4t₩10.6t₩622.0b27.8x110x6.4x
Thu, 05 May 2022₩69.6t₩10.0t₩866.3b27.2x80.4x7x
Sat, 02 Apr 2022₩75.2t₩9.9t₩855.8b25.4x87.9x7.6x
Mon, 28 Feb 2022₩70.1t₩9.4t₩783.3b33.1x89.5x7.5x
Wed, 26 Jan 2022₩74.7t₩9.4t₩787.4b32.8x94.9x8x
Fri, 24 Dec 2021₩93.0t₩9.4t₩787.4b39.2x118.1x9.9x
Sun, 21 Nov 2021₩95.5t₩9.2t₩1.0t43.1x91.2x10.4x
Tue, 19 Oct 2021₩96.9t₩9.2t₩986.0b39.7x98.3x10.5x
Thu, 16 Sep 2021₩115.6t₩9.3t₩946.2b44.6x122.1x12.4x
Sat, 14 Aug 2021₩117.8t₩9.3t₩909.7b49.4x129.5x12.7x
Wed, 09 Jun 2021₩101.8t₩9.0t₩979.0b45.3x104x11.3x
Tue, 02 Mar 2021₩89.7t₩8.2t₩501.3b44.6x179x10.9x
Price to Earnings Ratio

179x


Total Market Cap: ₩89.7tTotal Earnings: ₩501.3bTotal Revenue: ₩8.2tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Biotech Industry Price to Earnings3Y Average 30.2x202220232024
Current Industry PE
  • Investors are relatively neutral on the South Korean Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 7.6x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 5.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market1.76%
Healthcare1.04%
Biotech0.15%
Biotech0.15%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A196170 ALTEOGEN₩131.20k44.7%
+₩2.1t
243.9%PE1077.1x
A145020 Hugel₩182.40k6.7%
+₩129.0b
37.2%PE26.1x
A235980 MedPacto₩13.19k31.8%
+₩106.8b
-33.3%PB84.6x
A298380 ABL Bio₩22.50k10.3%
+₩100.6b
10.6%PS16x
A228760 Genomictree₩21.40k16.4%
+₩71.4b
86.1%PS114.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A302440

₩63,900.00

SK bioscienceLtd

7D

-1.4%

1Y

-9.9%

A145020

₩182,400.00

Hugel

7D

6.7%

1Y

37.2%

A298380

₩22,500.00

ABL Bio

7D

10.3%

1Y

10.6%

A228760

₩21,400.00

Genomictree

7D

16.4%

1Y

86.1%

A115450

₩8,430.00

HLB TherapeuticsLtd

7D

11.2%

1Y

56.2%

A196170

₩131,200.00

ALTEOGEN

7D

44.7%

1Y

243.9%

A182400

₩1,957.00

NKMAX

7D

-21.7%

1Y

-68.7%

A086900

₩184,000.00

Medy-Tox

7D

-3.1%

1Y

-13.6%

A068270

₩180,000.00

Celltrion

7D

-1.2%

1Y

20.6%

A235980

₩13,190.00

MedPacto

7D

31.8%

1Y

-33.3%

A214450

₩94,700.00

PharmaResearch

7D

-2.0%

1Y

29.4%

A215600

₩5,090.00

SillaJen

7D

-4.3%

1Y

-20.0%

A064550

₩25,950.00

Bioneer

7D

-4.2%

1Y

-49.2%

A310210

₩41,700.00

Voronoi

7D

9.6%

1Y

81.3%

A358570

₩10,520.00

GI Innovation

7D

-5.7%

1Y

n/a